EUVIMEDEUVIMED entdecken
Crossref

Non‐Apoptotic Inhibition of Colorectal Cancer Proliferation by Sclareol via Ferroptosis Involving SLC7A11 / GPX4 Modulation

Yu-Xi Li, Yuan Wu, Qiong Li, Yu-Qing Huang, Ying-Ying Yuan, Yan-Ni Su, Chien-Shan Cheng, Lan Zheng iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.70010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Yu-Xi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms, Phospholipid Hydroperoxide Glutathione Peroxidase, Amino Acid Transport System y+. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a prevalent and lethal malignancy necessitating new treatments. Sclareol, the primary active component of Salvia sclarea L., exhibits diverse pharmacological properties, making it a promising anti‐cancer drug warranting further investigation. To evaluate Sclareol's action in CRC cell death, various methods were performed, including cell viability and colony formation assays, EdU assay, flow cytometry for cell cycle analysis and apoptosis, as well as TUNEL staining, transmission electron microscopy (TEM), reactive oxygen species (ROS) detection, and Fe 2+ fluorometric assay. RNA sequencing and pathway analysis, combined with in silico molecular docking, and immunoblotting, were conducted to determine the mechanism of action of Sclareol. A CRC xenograft model in immunocompetent mice was used to evaluate Sclareol's in vivo efficacy and toxicity, with immunohistochemistry confirming its mechanism of action. Sclareol significantly suppressed CRC cell proliferation and induced cell cycle arrest in vitro without significantly inducing apoptosis. Ferroptosis as a promising mechanism of action was validated through TEM, ROS detection, and Fe 2+ staining. RNA sequencing analysis revealed enrichment in metal ion‐transporter activity. Molecular docking analysis showed direct binding of Sclareol to the key ferroptosis‐related target solute carrier family 7 member 11 (SLC7A11). Additionally, Sclareol downregulated the expression of SLC7A11, nuclear factor erythroid 2‐related factor 2 (Nrf2), and glutathione peroxidase 4 (GPX4) proteins, indicating ferroptosis induction in vitro. Significant tumor growth inhibition was observed without hepatic or renal toxicities, with immunohistochemistry confirming the suppression of ferroptosis‐ and proliferation‐related markers in vivo. Sclareol inhibits CRC growth by modulating the ferroptosis pathway through the SLC7A11/GPX4 axis. Sclareol shows promise as a therapeutic agent in CRC, warranting further pre‐clinical studies to confirm its efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsPhospholipid Hydroperoxide Glutathione PeroxidaseAmino Acid Transport System y+DiterpenesAntineoplastic Agents, PhytogenicHumansAnimalsCell ProliferationMiceReactive Oxygen SpeciesCell Line, TumorMolecular Docking SimulationApoptosisXenograft Model Antitumor AssaysMice, Inbred BALB CCell Cycle Checkpoints

Stichwörter der Autor:innen

SLC7A11Sclareolapoptosis‐independentcell deathcolorectal cancerferroptosis

Substanzen

Phospholipid Hydroperoxide Glutathione PeroxidaseAmino Acid Transport System y+Reactive Oxygen SpeciesSLC7A11 protein, humansclareolDiterpenesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China.
  • Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Lan Zheng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Y. X., Wu, Y., Li, Q., Huang, Y. Q., Yuan, Y. Y., Su, Y. N., Cheng, C. S., & Zheng, L. (2025). Non‐Apoptotic Inhibition of Colorectal Cancer Proliferation by Sclareol via Ferroptosis Involving SLC7A11 / GPX4 Modulation. Phytotherapy Research. https://doi.org/10.1002/ptr.70010

Vancouver

Li YX, Wu Y, Li Q, Huang YQ, Yuan YY, Su YN, et al. Non‐Apoptotic Inhibition of Colorectal Cancer Proliferation by Sclareol via Ferroptosis Involving SLC7A11 / GPX4 Modulation. Phytotherapy Research. 2025. doi:10.1002/ptr.70010

BibTeX
@article{Li2025,
  author = {Li, Yu-Xi and Wu, Yuan and Li, Qiong and Huang, Yu-Qing and Yuan, Ying-Ying and Su, Yan-Ni and Cheng, Chien-Shan and Zheng, Lan},
  title = {Non‐Apoptotic Inhibition of Colorectal Cancer Proliferation by Sclareol via Ferroptosis Involving SLC7A11 / GPX4 Modulation},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.70010}
}
Kostenlos starten →